Biofrontera (BFRI) Total Liabilities (2020 - 2026)
Biofrontera (BFRI) posted quarterly Total Liabilities of $18.1 million for Q4 2025, up 2.35% year-over-year from $17.7 million in Q4 2024, and little changed quarter-over-quarter from $18.0 million in Q3 2025.
Biofrontera (BFRI) Total Liabilities (2020 - 2026) Analysis & Trends
Biofrontera's Total Liabilities history runs 6 years deep, the most recent figure standing at $18.1 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 2.35% year-over-year to $18.1 million; the TTM figure through Dec 2025 stood at $18.1 million (up 2.35% YoY), while the FY2025 annual figure was $18.1 million, up 2.35% from the prior year.
- Total Liabilities for Q4 2025 stood at $18.1 million, roughly flat from $18.0 million in the prior quarter.
- The five-year high for Total Liabilities was $41.9 million in Q4 2021, with the low at $10.7 million in Q2 2024.
- The 5-year median for Total Liabilities is $25.2 million (2023), against an average of $25.2 million.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities sank 60.73% in 2024, then surged 132.67% in 2025.
- Biofrontera's Total Liabilities stood at $41.9 million in 2021, then tumbled by 35.52% to $27.0 million in 2022, then dropped by 14.32% to $23.1 million in 2023, then declined by 23.64% to $17.7 million in 2024, then advanced by 2.35% to $18.1 million in 2025.
- Business Quant data shows BFRI's Total Liabilities at $18.1 million in Q4 2025, $18.0 million in Q3 2025, and $24.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 18.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.11 Mn |
| Dec 31, 2025 | 18.08 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 24.81 Mn |
| Mar 31, 2025 | 16.12 Mn |
| Dec 31, 2024 | 17.67 Mn |
| Sep 30, 2024 | 12.99 Mn |
| Jun 30, 2024 | 10.66 Mn |
| Mar 31, 2024 | 26.42 Mn |
| Dec 31, 2023 | 23.14 Mn |
| Sep 30, 2023 | 33.07 Mn |
| Mar 31, 2023 | 25.21 Mn |
| Dec 31, 2022 | 27.01 Mn |
| Sep 30, 2022 | 32.46 Mn |
| Jun 30, 2022 | 36.39 Mn |
| Mar 31, 2022 | 31.79 Mn |
| Dec 31, 2021 | 41.88 Mn |
| Sep 30, 2021 | 32.73 Mn |
| Dec 31, 2020 | 18.31 Mn |